Stefan A Lange
Overview
Explore the profile of Stefan A Lange including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engelbertz C, Marschall U, Feld J, Makowski L, Lange S, Freisinger E, et al.
J Intern Med
. 2024 Sep;
296(4):362-376.
PMID: 39221828
Background: Vitamin-K antagonists (VKAs) have widely been replaced by non-VKA oral anticoagulants (NOACs). This includes Austria, Germany and Switzerland, where as VKA, instead of warfarin, the much longer-acting phenprocoumon is...
2.
Fischer A, Feld J, Lange S, Gunster C, Droge P, Engelbertz C, et al.
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999354
: Specifically young women are at risk for a poor outcome after ST-elevation myocardial infarction (STEMI). We aimed to investigate sex- and age-specific differences in outcome and associate these results...
3.
Engelbertz C, Feld J, Makowski L, Lange S, Gunster C, Droge P, et al.
Clin Kidney J
. 2023 Nov;
16(11):1947-1956.
PMID: 37915929
Background: Survivors of myocardial infarction have an elevated risk of long-term mortality. We sought to evaluate guideline-directed medical treatment and its impact on long-term mortality in survivors of ST-elevation myocardial...
4.
Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies-A Real-World Analysis
Lange S, Schliemann C, Engelbertz C, Feld J, Makowski L, Gerss J, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894332
Background: The impact of the encounter between coronary heart disease (CHD) and cancer, and in particular hematologic malignancies (HM), remains poorly understood. Objective: The aim of this analysis was to...
5.
Kuehnemund L, Lange S, Feld J, Padberg J, Fischer A, Makowski L, et al.
Atherosclerosis
. 2023 May;
375:30-37.
PMID: 37245424
Background And Aims: Acute myocardial infarction (AMI) is the leading cause of death worldwide. Outcome has improved during the last decades due to secondary prevention and widespread coronary interventions, but...
6.
Engelbertz C, Feld J, Makowski L, Kuhnemund L, Fischer A, Lange S, et al.
BMC Cardiovasc Disord
. 2023 Feb;
23(1):62.
PMID: 36732721
Background: Cardiovascular disease is often associated with chronic kidney disease (CKD), resulting in an increased risk for poor outcome. We sought to determine short-term mortality and overall survival in ST-elevation...
7.
Makowski L, Feld J, Engelbertz C, Koppe J, Kuhnemund L, Fischer A, et al.
Gesundheitswesen
. 2022 Sep;
85(S 02):S127-S134.
PMID: 36170865
Aim Of The Study: The aim of our study was to analyse sex-specific differences in diagnosis and treatment of patients with lower extremity artery disease (LEAD) at Rutherford stage (RF)...
8.
Makowski L, Koppe J, Engelbertz C, Kuhnemund L, Fischer A, Lange S, et al.
Eur Heart J
. 2022 Feb;
43(18):1759-1770.
PMID: 35134893
Aims: The prevalence of chronic limb-threatening ischaemia (CLTI) is increasing and available data often derive from cohorts with various selection criteria. In the present study, we included CLTI patients and...
9.
Lange S, Reinecke H
Cancers (Basel)
. 2022 Jan;
14(2).
PMID: 35053596
Cardiovascular disease and cancer remain the leading causes of hospitalization and mortality in high-income countries. Survival after myocardial infarction has improved but there is still a difference in clinical outcome,...
10.
Lange S, Feld J, Kuhnemund L, Koppe J, Makowski L, Engelbertz C, et al.
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944823
Background: Acute myocardial infarction (AMI) and cancer are common and serious diseases. As the prognosis and treatment of both diseases has improved, more cancer patients will suffer an AMI. Unfortunately,...